Myelogenous Leukemia Philadelphia Chromosome Positive Bcr-abl1 Positive

• CLINICAL_TRIALS trial_result · 2023-07-17
  Clinical Trial Update: Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML [Phase 1, Phase 2]

  Phase I/II study evaluating bosutinib combined with inotuzumab ozogamicin in CD22-positive ALL and CML showed completed status with results …